List of Tables
Table 1. Migraine Therapeutics Market Trends
Table 2. Migraine Therapeutics Market Drivers & Opportunity
Table 3. Migraine Therapeutics Market Challenges
Table 4. Migraine Therapeutics Market Restraints
Table 5. Global Migraine Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Migraine Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Migraine Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Migraine Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Migraine Therapeutics
Table 10. Global Migraine Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Migraine Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Migraine Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Migraine Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Migraine Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Migraine Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Migraine Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Migraine Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Migraine Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Migraine Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Migraine Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Migraine Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Migraine Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Migraine Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Migraine Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Migraine Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Migraine Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Migraine Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Migraine Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Allergan Basic Information List
Table 32. Allergan Description and Business Overview
Table 33. Allergan Migraine Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Migraine Therapeutics Business of Allergan (2019-2024)
Table 35. Allergan Recent Developments
Table 36. Merck Basic Information List
Table 37. Merck Description and Business Overview
Table 38. Merck Migraine Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Migraine Therapeutics Business of Merck (2019-2024)
Table 40. Merck Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Migraine Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Migraine Therapeutics Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Teva Basic Information List
Table 47. Teva Description and Business Overview
Table 48. Teva Migraine Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Migraine Therapeutics Business of Teva (2019-2024)
Table 50. Teva Recent Developments
Table 51. Amgen Basic Information List
Table 52. Amgen Description and Business Overview
Table 53. Amgen Migraine Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Migraine Therapeutics Business of Amgen (2019-2024)
Table 55. Amgen Recent Developments
Table 56. Johnson & Johnson Basic Information List
Table 57. Johnson & Johnson Description and Business Overview
Table 58. Johnson & Johnson Migraine Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Migraine Therapeutics Business of Johnson & Johnson (2019-2024)
Table 60. Johnson & Johnson Recent Developments
Table 61. Endo International Basic Information List
Table 62. Endo International Description and Business Overview
Table 63. Endo International Migraine Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Migraine Therapeutics Business of Endo International (2019-2024)
Table 65. Endo International Recent Developments
Table 66. GlaxoSmithKline Basic Information List
Table 67. GlaxoSmithKline Description and Business Overview
Table 68. GlaxoSmithKline Migraine Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Migraine Therapeutics Business of GlaxoSmithKline (2019-2024)
Table 70. GlaxoSmithKline Recent Developments
Table 71. Impax Basic Information List
Table 72. Impax Description and Business Overview
Table 73. Impax Migraine Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Migraine Therapeutics Business of Impax (2019-2024)
Table 75. Impax Recent Developments
Table 76. Abbott Basic Information List
Table 77. Abbott Description and Business Overview
Table 78. Abbott Migraine Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Migraine Therapeutics Business of Abbott (2019-2024)
Table 80. Abbott Recent Developments
Table 81. Bayer Basic Information List
Table 82. Bayer Description and Business Overview
Table 83. Bayer Migraine Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Migraine Therapeutics Business of Bayer (2019-2024)
Table 85. Bayer Recent Developments
Table 86. Eli Lilly Basic Information List
Table 87. Eli Lilly Description and Business Overview
Table 88. Eli Lilly Migraine Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Migraine Therapeutics Business of Eli Lilly (2019-2024)
Table 90. Eli Lilly Recent Developments
Table 91. Novartis International Basic Information List
Table 92. Novartis International Description and Business Overview
Table 93. Novartis International Migraine Therapeutics Products, Services and Solutions
Table 94. Revenue (US$ Million) in Migraine Therapeutics Business of Novartis International (2019-2024)
Table 95. Novartis International Recent Developments
Table 96. Ethypharm Basic Information List
Table 97. Ethypharm Description and Business Overview
Table 98. Ethypharm Migraine Therapeutics Products, Services and Solutions
Table 99. Revenue (US$ Million) in Migraine Therapeutics Business of Ethypharm (2019-2024)
Table 100. Ethypharm Recent Developments
Table 101. Kowa Pharmaceuticals America Basic Information List
Table 102. Kowa Pharmaceuticals America Description and Business Overview
Table 103. Kowa Pharmaceuticals America Migraine Therapeutics Products, Services and Solutions
Table 104. Revenue (US$ Million) in Migraine Therapeutics Business of Kowa Pharmaceuticals America (2019-2024)
Table 105. Kowa Pharmaceuticals America Recent Developments
Table 106. Winston Pharmaceuticals Basic Information List
Table 107. Winston Pharmaceuticals Description and Business Overview
Table 108. Winston Pharmaceuticals Migraine Therapeutics Products, Services and Solutions
Table 109. Revenue (US$ Million) in Migraine Therapeutics Business of Winston Pharmaceuticals (2019-2024)
Table 110. Winston Pharmaceuticals Recent Developments
Table 111. AstraZeneca Basic Information List
Table 112. AstraZeneca Description and Business Overview
Table 113. AstraZeneca Migraine Therapeutics Products, Services and Solutions
Table 114. Revenue (US$ Million) in Migraine Therapeutics Business of AstraZeneca (2019-2024)
Table 115. AstraZeneca Recent Developments
Table 116. Amirall Basic Information List
Table 117. Amirall Description and Business Overview
Table 118. Amirall Migraine Therapeutics Products, Services and Solutions
Table 119. Revenue (US$ Million) in Migraine Therapeutics Business of Amirall (2019-2024)
Table 120. Amirall Recent Developments
Table 121. OptiNose Basic Information List
Table 122. OptiNose Description and Business Overview
Table 123. OptiNose Migraine Therapeutics Products, Services and Solutions
Table 124. Revenue (US$ Million) in Migraine Therapeutics Business of OptiNose (2019-2024)
Table 125. OptiNose Recent Developments
Table 126. Revance Therapeutics Basic Information List
Table 127. Revance Therapeutics Description and Business Overview
Table 128. Revance Therapeutics Migraine Therapeutics Products, Services and Solutions
Table 129. Revenue (US$ Million) in Migraine Therapeutics Business of Revance Therapeutics (2019-2024)
Table 130. Revance Therapeutics Recent Developments
Table 131. RedHill Biopharma Basic Information List
Table 132. RedHill Biopharma Description and Business Overview
Table 133. RedHill Biopharma Migraine Therapeutics Products, Services and Solutions
Table 134. Revenue (US$ Million) in Migraine Therapeutics Business of RedHill Biopharma (2019-2024)
Table 135. RedHill Biopharma Recent Developments
Table 136. Bausch Health Basic Information List
Table 137. Bausch Health Description and Business Overview
Table 138. Bausch Health Migraine Therapeutics Products, Services and Solutions
Table 139. Revenue (US$ Million) in Migraine Therapeutics Business of Bausch Health (2019-2024)
Table 140. Bausch Health Recent Developments
Table 141. NeurAxon Basic Information List
Table 142. NeurAxon Description and Business Overview
Table 143. NeurAxon Migraine Therapeutics Products, Services and Solutions
Table 144. Revenue (US$ Million) in Migraine Therapeutics Business of NeurAxon (2019-2024)
Table 145. NeurAxon Recent Developments
Table 146. Biohaven Pharma Basic Information List
Table 147. Biohaven Pharma Description and Business Overview
Table 148. Biohaven Pharma Migraine Therapeutics Products, Services and Solutions
Table 149. Revenue (US$ Million) in Migraine Therapeutics Business of Biohaven Pharma (2019-2024)
Table 150. Biohaven Pharma Recent Developments
Table 151. Eisai Basic Information List
Table 152. Eisai Description and Business Overview
Table 153. Eisai Migraine Therapeutics Products, Services and Solutions
Table 154. Revenue (US$ Million) in Migraine Therapeutics Business of Eisai (2019-2024)
Table 155. Eisai Recent Developments
Table 156. Valeant Pharma Basic Information List
Table 157. Valeant Pharma Description and Business Overview
Table 158. Valeant Pharma Migraine Therapeutics Products, Services and Solutions
Table 159. Revenue (US$ Million) in Migraine Therapeutics Business of Valeant Pharma (2019-2024)
Table 160. Valeant Pharma Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Migraine Therapeutics Downstream Customers
Table 164. Migraine Therapeutics Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
Table 168. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Migraine Therapeutics Product Picture
Figure 2. Global Migraine Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Migraine Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Migraine Therapeutics Report Years Considered
Figure 5. Global Migraine Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Migraine Therapeutics Revenue in 2023
Figure 7. Migraine Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Specific Anti-migraine Drugs Picture
Figure 9. Acute Therapies Picture
Figure 10. Preventative Therapies Picture
Figure 11. Other Picture
Figure 12. Global Migraine Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Migraine Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hospitals
Figure 15. Product Picture of Clinics
Figure 16. Product Picture of Household Use
Figure 17. Product Picture of Others
Figure 18. Global Migraine Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Migraine Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Migraine Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Migraine Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Migraine Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Migraine Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Migraine Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Migraine Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Migraine Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Migraine Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Migraine Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Migraine Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Migraine Therapeutics Sales Value (%), (2019-2030)
Figure 31. United States Migraine Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Migraine Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Migraine Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Migraine Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Migraine Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Migraine Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 37. China Migraine Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Migraine Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 39. China Migraine Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Migraine Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Migraine Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Migraine Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Migraine Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Migraine Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Migraine Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Migraine Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Migraine Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Migraine Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 49. India Migraine Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Migraine Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 51. India Migraine Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 52. Migraine Therapeutics Industrial Chain
Figure 53. Migraine Therapeutics Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
